Doctor profile · Federal record

Dr. Andrew Kovoor, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Student in an Organized Health Care Education/Training Program · Plano, TX

  • NPI 1407119464
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 14 yrs in practice
  • Licensed in 2 states
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
4708 Alliance Blvd Ste 150
Plano, TX 75093
(972) 596-7801
fax (972) 596-9307
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
June 2012 — 14 yrs on file
Profile last updated
September 17, 2021
Year of graduation
2012 — 14 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State licenses (2)
Texas #R5884 · Arizona #R73264
Medicaid (2)
TX #384656002 · TX #384656001

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1407119464. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
108,471
Distinct HCPCS
10
Medicare allowed
$1,242,121
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 34,680 48 $0
J9263 Injection, oxaliplatin, 0.5 mg 12,140 13 $0
J9271 Injection, pembrolizumab, 1 mg 11,300 20 $54
J1756 Injection, iron sucrose, 1 mg 11,000 30 $0
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 9,891 104 $0
J9267 Injection, paclitaxel, 1 mg 5,256 16 $0
J9041 Injection, bortezomib, 0.1 mg 3,185 13 $4
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,966 95 $0
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 2,915 17 $3
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg 2,282 14 $31

In context: peer comparison

Among 6 peers in Plano Hematology & Oncology Physician, average services per provider: 1,308. This provider delivers 83× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,258
Transactions
82
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 28 $1,356.65
AstraZeneca Pharmaceuticals Lp 3 $557.72
Merck Sharp & Dohme LLC 12 $223.82
E.R. Squibb & Sons, L.L.C. 8 $140.71
Gilead Sciences, INC. 6 $123.94
Incyte Corporation 2 $107.70
Pfizer INC. 5 $102.98
Astellas Pharma US INC 1 $99.95
Abbvie INC. 5 $95.89
Regeneron Healthcare Solutions, INC. 1 $89.48
GlaxoSmithKline, LLC. 3 $58.15
Array Biopharma INC 3 $41.23
Emd Serono, INC. 1 $30.82
Genzyme Corporation 2 $30.73
Janssen Biotech, INC. 2 $30.58

By nature of payment

Food and Beverage
$1,428
Long Term Medical Supply or Device Loan
$1,097
Consulting Fee
$525
Education
$208

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
279
Patients
14
Total drug cost
$865,131
Drug Type Claims Patients Total cost
Eliquis (Apixaban) Brand 48 14 $33,570
Anastrozole Generic 34 0 $986
Hydroxyurea Generic 27 0 $930
Lenalidomide Generic 19 0 $280,313
Letrozole Generic 18 0 $560
Warfarin Sodium Generic 17 0 $190
Xarelto (Rivaroxaban) Brand 17 0 $13,753
Prochlorperazine Maleate Generic 16 0 $662
Dexamethasone Generic 13 0 $231
Retacrit (Epoetin Alfa-Epbx) Brand 13 0 $12,510

Frequently asked questions

Auto-generated from federal data
What is Dr. Andrew Kovoor's medical specialty?
Dr. Andrew Kovoor practices Hematology & Oncology Physician in Plano, TX.
Where does Dr. Andrew Kovoor practice?
Dr. Andrew Kovoor practices at 4708 Alliance Blvd Ste 150, Plano, TX 75093. Office phone: 9725967801.
What is Dr. Andrew Kovoor's NPI?
Dr. Andrew Kovoor's National Provider Identifier (NPI) is 1407119464, issued by NPPES.
Does Dr. Andrew Kovoor accept Medicare assignment?
Yes. Dr. Andrew Kovoor accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Andrew Kovoor commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, oxaliplatin, 0.5 mg (HCPCS J9263); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.